Literature DB >> 21791418

Identification of a specific intronic PEAR1 gene variant associated with greater platelet aggregability and protein expression.

Nauder Faraday1, Lisa R Yanek, Xiao Ping Yang, Rasika Mathias, J Enrique Herrera-Galeano, Bhoom Suktitipat, Rehan Qayyum, Andrew D Johnson, Ming-Huei Chen, Geoffrey H Tofler, Ingo Ruczinski, Alan D Friedman, Arnaldur Gylfason, Unnur Thorsteinsdottir, Paul F Bray, Christopher J O'Donnell, Diane M Becker, Lewis C Becker.   

Abstract

Genetic variation is thought to contribute to variability in platelet function; however, the specific variants and mechanisms that contribute to altered platelet function are poorly defined. With the use of a combination of fine mapping and sequencing of the platelet endothelial aggregation receptor 1 (PEAR1) gene we identified a common variant (rs12041331) in intron 1 that accounts for ≤ 15% of total phenotypic variation in platelet function. Association findings were robust in 1241 persons of European ancestry (P = 2.22 × 10⁻⁸) and were replicated down to the variant and nucleotide level in 835 persons of African ancestry (P = 2.31 × 10⁻²⁷) and in an independent sample of 2755 persons of European descent (P = 1.64 × 10⁻⁵). Sequencing confirmed that variation at rs12041331 accounted most strongly (P = 2.07 × 10⁻⁶) for the relation between the PEAR1 gene and platelet function phenotype. A dose-response relation between the number of G alleles at rs12041331 and expression of PEAR1 protein in human platelets was confirmed by Western blotting and ELISA. Similarly, the G allele was associated with greater protein expression in a luciferase reporter assay. These experiments identify the precise genetic variant in PEAR1 associated with altered platelet function and provide a plausible biologic mechanism to explain the association between variation in the PEAR1 gene and platelet function phenotype.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21791418      PMCID: PMC3179402          DOI: 10.1182/blood-2010-11-320788

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  20 in total

1.  Principal components analysis corrects for stratification in genome-wide association studies.

Authors:  Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich
Journal:  Nat Genet       Date:  2006-07-23       Impact factor: 38.330

2.  Heritability of platelet function in families with premature coronary artery disease.

Authors:  P F Bray; R A Mathias; N Faraday; L R Yanek; M D Fallin; J E Herrera-Galeano; A F Wilson; L C Becker; D M Becker
Journal:  J Thromb Haemost       Date:  2007-08       Impact factor: 5.824

3.  A common variant on chromosome 9p21 affects the risk of myocardial infarction.

Authors:  Anna Helgadottir; Gudmar Thorleifsson; Andrei Manolescu; Solveig Gretarsdottir; Thorarinn Blondal; Aslaug Jonasdottir; Adalbjorg Jonasdottir; Asgeir Sigurdsson; Adam Baker; Arnar Palsson; Gisli Masson; Daniel F Gudbjartsson; Kristinn P Magnusson; Karl Andersen; Allan I Levey; Valgerdur M Backman; Sigurborg Matthiasdottir; Thorbjorg Jonsdottir; Stefan Palsson; Helga Einarsdottir; Steinunn Gunnarsdottir; Arnaldur Gylfason; Viola Vaccarino; W Craig Hooper; Muredach P Reilly; Christopher B Granger; Harland Austin; Daniel J Rader; Svati H Shah; Arshed A Quyyumi; Jeffrey R Gulcher; Gudmundur Thorgeirsson; Unnur Thorsteinsdottir; Augustine Kong; Kari Stefansson
Journal:  Science       Date:  2007-05-03       Impact factor: 47.728

4.  Genetic and environmental contributions to platelet aggregation: the Framingham heart study.

Authors:  C J O'Donnell; M G Larson; D Feng; P A Sutherland; K Lindpaintner; R H Myers; R A D'Agostino; D Levy; G H Tofler
Journal:  Circulation       Date:  2001-06-26       Impact factor: 29.690

5.  Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin-treated patients.

Authors:  T Ohmori; Y Yatomi; T Nonaka; Y Kobayashi; S Madoiwa; J Mimuro; Y Ozaki; Y Sakata
Journal:  J Thromb Haemost       Date:  2006-06       Impact factor: 5.824

6.  Platelet endothelial aggregation receptor 1 (PEAR1), a novel epidermal growth factor repeat-containing transmembrane receptor, participates in platelet contact-induced activation.

Authors:  Nisha Nanda; Ming Bao; Hanna Lin; Karl Clauser; Laszlo Komuves; Thomas Quertermous; Pamela B Conley; David R Phillips; Matthew J Hart
Journal:  J Biol Chem       Date:  2005-04-25       Impact factor: 5.157

7.  Heritability of platelet responsiveness to aspirin in activation pathways directly and indirectly related to cyclooxygenase-1.

Authors:  Nauder Faraday; Lisa R Yanek; Rasika Mathias; J Enrique Herrera-Galeano; Dhananjay Vaidya; Taryn F Moy; M Daniele Fallin; Alexander F Wilson; Paul F Bray; Lewis C Becker; Diane M Becker
Journal:  Circulation       Date:  2007-04-30       Impact factor: 29.690

8.  Sex differences in platelet reactivity and response to low-dose aspirin therapy.

Authors:  Diane M Becker; Jodi Segal; Dhananjay Vaidya; Lisa R Yanek; J Enrique Herrera-Galeano; Paul F Bray; Taryn F Moy; Lewis C Becker; Nauder Faraday
Journal:  JAMA       Date:  2006-03-22       Impact factor: 56.272

Review 9.  Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and meta-analysis.

Authors:  Jaapjan D Snoep; Marcel M C Hovens; Jeroen C J Eikenboom; Johanna G van der Bom; Menno V Huisman
Journal:  Arch Intern Med       Date:  2007 Aug 13-27

10.  A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease.

Authors:  Patricia A Gum; Kandice Kottke-Marchant; Patricia A Welsh; Jennifer White; Eric J Topol
Journal:  J Am Coll Cardiol       Date:  2003-03-19       Impact factor: 24.094

View more
  37 in total

Review 1.  The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19.

Authors:  Yao Yang; Joshua P Lewis; Jean-Sébastien Hulot; Stuart A Scott
Journal:  Expert Opin Drug Metab Toxicol       Date:  2015-07-14       Impact factor: 4.481

2.  Shared gene expression patterns in mesenchymal progenitors derived from lung and epidermis in pulmonary arterial hypertension: identifying key pathways in pulmonary vascular disease.

Authors:  Christa Gaskill; Shennea Marriott; Sidd Pratap; Swapna Menon; Lora K Hedges; Joshua P Fessel; Jonathan A Kropski; DeWayne Ames; Lisa Wheeler; James E Loyd; Anna R Hemnes; Dennis R Roop; Dwight J Klemm; Eric D Austin; Susan M Majka
Journal:  Pulm Circ       Date:  2016-12       Impact factor: 3.017

3.  Replication and hematological characterization of human platelet reactivity genetic associations in men from the Caerphilly Prospective Study (CaPS).

Authors:  John D Eicher; Luting Xue; Yoav Ben-Shlomo; Andrew D Beswick; Andrew D Johnson
Journal:  J Thromb Thrombolysis       Date:  2016-02       Impact factor: 2.300

4.  Pairing megakaryopoiesis methylation with PEAR1.

Authors:  Andrew D Johnson
Journal:  Blood       Date:  2016-08-18       Impact factor: 22.113

Review 5.  PEAR1 polymorphisms as a prognostic factor in hemostasis and cardiovascular diseases.

Authors:  Narges Ansari; Sahar Najafi; Saied Shahrabi; Najmaldin Saki
Journal:  J Thromb Thrombolysis       Date:  2021-01       Impact factor: 2.300

6.  Genetic Variation in PEAR1, Cardiovascular Outcomes and Effects of Aspirin in a Healthy Elderly Population.

Authors:  Joshua P Lewis; Moeen Riaz; Sophia Xie; Galina Polekhina; Rory Wolfe; Mark Nelson; Andrew M Tonkin; Christopher M Reid; Anne M Murray; John J McNeil; Alan R Shuldiner; Paul Lacaze
Journal:  Clin Pharmacol Ther       Date:  2020-07-20       Impact factor: 6.875

7.  Aspirin exposure reveals novel genes associated with platelet function and cardiovascular events.

Authors:  Deepak Voora; Derek Cyr; Joseph Lucas; Jen-Tsan Chi; Jennifer Dungan; Timothy A McCaffrey; Richard Katz; L Kristin Newby; William E Kraus; Richard C Becker; Thomas L Ortel; Geoffrey S Ginsburg
Journal:  J Am Coll Cardiol       Date:  2013-07-03       Impact factor: 24.094

8.  Associations of MDR1, TBXA2R, PLA2G7, and PEAR1 genetic polymorphisms with the platelet activity in Chinese ischemic stroke patients receiving aspirin therapy.

Authors:  Ling-Ling Peng; Yuan-Qi Zhao; Zi-Yi Zhou; Jing Jin; Min Zhao; Xin-Meng Chen; Ling-Yan Chen; Ye-Feng Cai; Jia-Li Li; Min Huang
Journal:  Acta Pharmacol Sin       Date:  2016-09-19       Impact factor: 6.150

9.  Targeted deep sequencing of the PEAR1 locus for platelet aggregation in European and African American families.

Authors:  Ali R Keramati; Lisa R Yanek; Kruthika Iyer; Margaret A Taub; Ingo Ruczinski; Diane M Becker; Lewis C Becker; Nauder Faraday; Rasika A Mathias
Journal:  Platelets       Date:  2018-03-19       Impact factor: 3.862

10.  Synthetic glycopolymers and natural fucoidans cause human platelet aggregation via PEAR1 and GPIbα.

Authors:  Caroline Kardeby; Knut Fälker; Elizabeth J Haining; Maarten Criel; Madelene Lindkvist; Ruben Barroso; Peter Påhlsson; Liza U Ljungberg; Mattias Tengdelius; G Ed Rainger; Stephanie Watson; Johannes A Eble; Marc F Hoylaerts; Jonas Emsley; Peter Konradsson; Steve P Watson; Yi Sun; Magnus Grenegård
Journal:  Blood Adv       Date:  2019-02-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.